110 related articles for article (PubMed ID: 7301281)
1. Prednisolone plasma levels after oral administration of Prednimustine. Comparison with levels obtained after administration of an equimolar dose of prednisolone.
Sayed A; Hove WV; Vermeulen A
Oncology; 1981; 38(6):351-5. PubMed ID: 7301281
[TBL] [Abstract][Full Text] [Related]
2. Comparative pharmacokinetics of chlorambucil and prednimustine after oral administration.
Loos U; Musch E; Malek M; Riedel E
Oncology; 1991; 48(4):334-42. PubMed ID: 1891177
[TBL] [Abstract][Full Text] [Related]
3. Studies on the pharmacokinetics of chlorambucil and prednimustine in man.
Newell DR; Calvert AH; Harrap KR; McElwain TJ
Br J Clin Pharmacol; 1983 Feb; 15(2):253-8. PubMed ID: 6849759
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of chlorambucil in man after administration of the free drug and its prednisolone ester (prednimustine, Leo 1031).
Ehrsson H; Wallin I; Nilsson SO; Johansson B
Eur J Clin Pharmacol; 1983; 24(2):251-3. PubMed ID: 6840176
[TBL] [Abstract][Full Text] [Related]
5. A pharmacokinetic study of prednimustine as compared with prednisolone plus chlorambucil in cancer patients.
Bastholt L; Johansson CJ; Pfeiffer P; Svensson L; Johansson SA; Gunnarsson PO; Mouridsen H
Cancer Chemother Pharmacol; 1991; 28(3):205-10. PubMed ID: 1855277
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity and metabolism of prednimustine, chlorambucil and prednisolone in a Chinese hamster cell line.
Hartley-Asp B; Gunnarsson PO; Liljekvist J
Cancer Chemother Pharmacol; 1986; 16(2):85-90. PubMed ID: 3948307
[TBL] [Abstract][Full Text] [Related]
7. Disposition of orally administered 14C-prednimustine in cancer patients.
Gaver RC; Deeb G; Pittman KA; Issell BF; Mittelman A; Smyth RD
Cancer Chemother Pharmacol; 1983; 11(3):139-43. PubMed ID: 6640823
[TBL] [Abstract][Full Text] [Related]
8. Studies on the pharmacokinetics of chlorambucil and prednimustine in patients using a new high-performance liquid chromatographic assay.
Oppitz MM; Musch E; Malek M; Rüb HP; von Unruh GE; Loos U; Mühlenbruch B
Cancer Chemother Pharmacol; 1989; 23(4):208-12. PubMed ID: 2924378
[TBL] [Abstract][Full Text] [Related]
9. Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone.
Ideström K; Kimby E; Björkholm M; Mellstedt H; Engstedt L; Gahrton G; Johansson B; Killander D; Robérts KH; Stalfelt AM; Udén AM; Wadman B; Wählby S
Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1117-23. PubMed ID: 6897633
[TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics of prednimustine and chlorambucil in the rat.
Newell DR; Shepherd CR; Harrap KR
Cancer Chemother Pharmacol; 1981; 6(1):85-91. PubMed ID: 7273268
[TBL] [Abstract][Full Text] [Related]
11. A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer.
Løber J; Mouridsen HT; Christiansen IE; Dombernowsky P; Mattsson W; Rørth M
Cancer; 1983 Nov; 52(9):1570-6. PubMed ID: 6352005
[TBL] [Abstract][Full Text] [Related]
12. The antitumor effect of prednimustine in vitro and in vivo.
Hartley-Asp B
Semin Oncol; 1986 Mar; 13(1 Suppl 1):3-7. PubMed ID: 3952519
[TBL] [Abstract][Full Text] [Related]
13. Comparative carcinogenic activity of prednimustine, chlorambucil, prednisolone and chlorambucil plus prednisolone in Sprague-Dawley rats.
Berger MR; Habs M; Schmähl D
Arch Geschwulstforsch; 1985; 55(6):429-42. PubMed ID: 4083998
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the cytotoxic effect of prednimustine in cultured cells with high or low levels of metallothionein.
Endresen L
Acta Pharmacol Toxicol (Copenh); 1984 Jan; 54(1):49-57. PubMed ID: 6702467
[TBL] [Abstract][Full Text] [Related]
15. Prednimustine in refractory non-Hodgkin's lymphoma: a phase II study of the Northern California Oncology Group.
Gandara DR; Wold HG; Redmond J; Kohler M; Reynolds R; Wong P; Forsythe J; Fisher K; Lewis B
Semin Oncol; 1986 Mar; 13(1 Suppl 1):14-8. PubMed ID: 3952517
[TBL] [Abstract][Full Text] [Related]
16. Long-term toxicology effects of prednimustine in comparison with chlorambucil, prednisolone, and chlorambucil plus prednisolone in Sprague-Dawley rats.
Berger MR; Habs M; Schmähl D
Semin Oncol; 1986 Mar; 13(1 Suppl 1):8-13. PubMed ID: 3952521
[TBL] [Abstract][Full Text] [Related]
17. Clinical trial of prednimustine, Leo-1031 (NSC-134087), in patients with non-Hodgkin lymphomata and chronic lymphocytic leukaemia previously treated with steroids and alkylating agents.
Pedersen-Bjergaard J; Hansen MM; Geisler CH; Nissen NI
Acta Med Scand; 1980; 207(3):215-20. PubMed ID: 6989170
[TBL] [Abstract][Full Text] [Related]
18. A phase III study of prednimustine (LEO 1031) in advanced breast cancer. A preliminary report.
Rørth M; Løber J; Dombernowsky P; Krusenstjerna-Hofstrom D; Mattsson W; Mouridsen HT
Eur J Cancer (1965); 1980; Suppl 1():137-40. PubMed ID: 7032923
[No Abstract] [Full Text] [Related]
19. Prednimustine in combination with methotrexate and 5-FU (PMF): a pilot study.
Boesen E; Mouridsen HT
Cancer Treat Rep; 1982 Dec; 66(12):2081-3. PubMed ID: 7139649
[TBL] [Abstract][Full Text] [Related]
20. Prednimustine in advanced breast cancer: a review.
Mouridsen HT
Semin Oncol; 1986 Mar; 13(1 Suppl 1):27-31. PubMed ID: 3513318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]